Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011629
Filing Date
2024-08-08
Accepted
2024-08-08 16:39:04
Documents
90
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20240630x10q.htm   iXBRL 10-Q 2873471
2 EX-10.3 chrs-20240630xex10d3.htm EX-10.3 161105
3 EX-10.4 chrs-20240630xex10d4.htm EX-10.4 94488
4 EX-10.5 chrs-20240630xex10d5.htm EX-10.5 321865
5 EX-31.1 chrs-20240630xex31d1.htm EX-31.1 14071
6 EX-31.2 chrs-20240630xex31d2.htm EX-31.2 14964
7 EX-32.1 chrs-20240630xex32d1.htm EX-32.1 12066
  Complete submission text file 0001558370-24-011629.txt   12408721

Data Files

Seq Description Document Type Size
8 EX-101.SCH chrs-20240630.xsd EX-101.SCH 83453
9 EX-101.CAL chrs-20240630_cal.xml EX-101.CAL 92654
10 EX-101.DEF chrs-20240630_def.xml EX-101.DEF 370401
11 EX-101.LAB chrs-20240630_lab.xml EX-101.LAB 649708
12 EX-101.PRE chrs-20240630_pre.xml EX-101.PRE 529146
93 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240630x10q_htm.xml XML 2118573
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 241189124
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)